Jeong-yoon Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Comprehensive Prestroke Risk Factor Control and Functional Outcomes After Acute Ischemic Stroke.
Journal: Journal of the American Heart Association
Published: June 15, 2026
Annual Trends in Risk Factor Control Status at the Time of Ischemic Stroke in South Korea.
Journal: Journal of the American Heart Association
Published: February 20, 2026
Differential Effects of Admission Hemoglobin A1c by Estimated Glomerular Filtration Rate Stages on Mortality in Acute Ischemic Stroke and Diabetes.
Journal: Journal of the American Heart Association
Published: December 11, 2025
Year-Long Antibody Response to the EuCorVac-19 SARS-CoV-2 Vaccine in Healthy Filipinos.
Journal: Vaccines
Published: June 19, 2025
Nutritional compliance as a prognostic and quality indicator in the intensive care unit: Insights from nutrition support team-guided therapy.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: June 10, 2025
Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry.
Journal: Journal of Korean medical science
Published: May 27, 2024
Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.
Journal: Journal of medical virology
Published: March 10, 2024
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 06, 2023
Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.
Journal: Frontiers in immunology
Published: September 04, 2017
Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection.
Journal: Journal of microbiology (Seoul, Korea)
Published: July 28, 2017
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
Journal: PloS one
Published: September 13, 2016
Last Updated: 09/26/2026